Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifton O Bingham

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Current Allergy and Asthma Reports|July 9, 2008
Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory diseaseClifton O Bingham
The Journal of Rheumatology. Supplement|September 19, 2002
The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammationClifton O Bingham
Cleveland Clinic Journal of Medicine|June 28, 2002
Development and clinical application of COX-2-selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritisClifton O Bingham
Bulletin of the NYU Hospital for Joint Diseases|October 22, 2008
Emerging therapeutics for rheumatoid arthritisClifton O Bingham
Expert Opinion on Biological Therapy|April 12, 2014
Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritisHoma Timlin, Clifton O Bingham
Nature Clinical Practice. Rheumatology|June 11, 2008
Ethical issues in rheumatology clinical trialsJeremy Sugarman, Clifton O Bingham
Seminars in Arthritis and Rheumatism|January 21, 2014
Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitorsJulius Birnbaum, Clifton O Bingham
Current Opinion in Rheumatology|March 5, 2013
Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactionsClifton O Bingham, Malini Moni
Rheumatology (Oxford, England)|October 3, 2017
Towards improving measurement of stiffness in rheumatologyAna-Maria Orbai, Clifton O Bingham
Arthritis Research & Therapy|January 15, 2015
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseasesZsuzsanna H McMahan, Clifton O Bingham
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Current Allergy and Asthma Reports|July 9, 2008
Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory diseaseClifton O Bingham
The Journal of Rheumatology. Supplement|September 19, 2002
The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammationClifton O Bingham
Cleveland Clinic Journal of Medicine|June 28, 2002
Development and clinical application of COX-2-selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritisClifton O Bingham
Bulletin of the NYU Hospital for Joint Diseases|October 22, 2008
Emerging therapeutics for rheumatoid arthritisClifton O Bingham
Expert Opinion on Biological Therapy|April 12, 2014
Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritisHoma Timlin, Clifton O Bingham
Nature Clinical Practice. Rheumatology|June 11, 2008
Ethical issues in rheumatology clinical trialsJeremy Sugarman, Clifton O Bingham
Seminars in Arthritis and Rheumatism|January 21, 2014
Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitorsJulius Birnbaum, Clifton O Bingham
Current Opinion in Rheumatology|March 5, 2013
Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactionsClifton O Bingham, Malini Moni
Rheumatology (Oxford, England)|October 3, 2017
Towards improving measurement of stiffness in rheumatologyAna-Maria Orbai, Clifton O Bingham
Arthritis Research & Therapy|January 15, 2015
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseasesZsuzsanna H McMahan, Clifton O Bingham
Pageof 28